PetraHamerlik The University of ManchesterUnited Kingdom

Petra Hamerlik is an accomplished researcher in primary pharmacology and brain cancer research. Her professional career has been a blend of academic and industry roles, including positions at the Danish Cancer Society, Cleveland Clinic, and AstraZeneca. In September 2022, Petra was recruited to the University of Manchester as the Inaugural Brain Tumour Charity Chair of Translational Neuro-Oncology. Her current work is focused on identifying novel treatments and early detection of intracranial tumours.

Tuesday 09 June 2026

Time	Session

15:20 16:55	Symposium: Brain Tumours Room P1+2+3 JoanSeoane Co-Chair VHIO, Seoane LabSpain MircoJ.Friedrich Co-Chair German Cancer Research Center and HI-STEM GmbHGermany Brain Tumours: From Early Detection to Therapy PetraHamerlik Speaker The University of ManchesterUnited Kingdom Proffered Paper: Functional precision medicine screening in patient-derived organoids reveals personalized therapeutic vulnerabilities in adult high-grade gliomas EACR26-0578 EACR26-0578 AnnaGolebiewskaGolebiewska Oral Presenter Luxembourg Institute of HealthLuxembourg Targeting T cells to Brain Tumors Michael Platten Speaker University of Heildelberg, Medical Faculty MannheimGermany Proffered Paper: Dura-associated immune cell hubs drive effector T-cell responses to glioblastoma EACR26-1858 EACR26-1858 MichaelKilian Oral Presenter Brigham and Women's Hospital and Harvard Medical SchoolUnited States The immunosuppressive tumor microenvironment in glioblastoma JoanSeoane Speaker VHIO, Seoane LabSpain Room P1+2+3

Time

Session

15:20

16:55

Symposium: Brain Tumours

Room P1+2+3

JoanSeoane Co-Chair VHIO, Seoane LabSpain

MircoJ.Friedrich Co-Chair German Cancer Research Center and HI-STEM GmbHGermany

Brain Tumours: From Early Detection to Therapy

PetraHamerlik Speaker The University of ManchesterUnited Kingdom
Proffered Paper: Functional precision medicine screening in patient-derived organoids reveals personalized therapeutic vulnerabilities in adult high-grade gliomas

EACR26-0578

EACR26-0578

AnnaGolebiewskaGolebiewska Oral Presenter Luxembourg Institute of HealthLuxembourg
Targeting T cells to Brain Tumors

Michael Platten Speaker University of Heildelberg, Medical Faculty MannheimGermany
Proffered Paper: Dura-associated immune cell hubs drive effector T-cell responses to glioblastoma

EACR26-1858

EACR26-1858

MichaelKilian Oral Presenter Brigham and Women's Hospital and Harvard Medical SchoolUnited States
The immunosuppressive tumor microenvironment in glioblastoma

JoanSeoane Speaker VHIO, Seoane LabSpain

Room P1+2+3